CA2764877A1 - Device and methods for applying therapeutic protocols to organs of the cardiopulmonary system - Google Patents
Device and methods for applying therapeutic protocols to organs of the cardiopulmonary system Download PDFInfo
- Publication number
- CA2764877A1 CA2764877A1 CA2764877A CA2764877A CA2764877A1 CA 2764877 A1 CA2764877 A1 CA 2764877A1 CA 2764877 A CA2764877 A CA 2764877A CA 2764877 A CA2764877 A CA 2764877A CA 2764877 A1 CA2764877 A1 CA 2764877A1
- Authority
- CA
- Canada
- Prior art keywords
- add
- patient
- fpps
- protocol
- fpp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 59
- 230000001225 therapeutic effect Effects 0.000 title claims description 54
- 210000000056 organ Anatomy 0.000 title abstract description 6
- 230000002612 cardiopulmonary effect Effects 0.000 title description 12
- 239000012530 fluid Substances 0.000 claims abstract description 49
- 238000011282 treatment Methods 0.000 claims description 105
- 230000006872 improvement Effects 0.000 claims description 61
- 230000000694 effects Effects 0.000 claims description 50
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 48
- 230000036541 health Effects 0.000 claims description 39
- 238000012360 testing method Methods 0.000 claims description 39
- 210000004072 lung Anatomy 0.000 claims description 37
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 26
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 claims description 26
- 229960003753 nitric oxide Drugs 0.000 claims description 24
- 230000006870 function Effects 0.000 claims description 21
- 206010019280 Heart failures Diseases 0.000 claims description 19
- 230000000747 cardiac effect Effects 0.000 claims description 19
- 230000002685 pulmonary effect Effects 0.000 claims description 19
- 208000031229 Cardiomyopathies Diseases 0.000 claims description 16
- 208000006673 asthma Diseases 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 14
- 230000010355 oscillation Effects 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 13
- 238000009792 diffusion process Methods 0.000 claims description 13
- 206010007559 Cardiac failure congestive Diseases 0.000 claims description 12
- 230000036772 blood pressure Effects 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 12
- 230000000241 respiratory effect Effects 0.000 claims description 12
- 230000002085 persistent effect Effects 0.000 claims description 11
- 238000003860 storage Methods 0.000 claims description 10
- 230000009885 systemic effect Effects 0.000 claims description 10
- 201000003883 Cystic fibrosis Diseases 0.000 claims description 9
- 208000002815 pulmonary hypertension Diseases 0.000 claims description 9
- 230000000638 stimulation Effects 0.000 claims description 8
- 208000024891 symptom Diseases 0.000 claims description 8
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 7
- 201000001320 Atherosclerosis Diseases 0.000 claims description 6
- 206010035664 Pneumonia Diseases 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 6
- 230000004217 heart function Effects 0.000 claims description 6
- 230000003434 inspiratory effect Effects 0.000 claims description 6
- 238000006213 oxygenation reaction Methods 0.000 claims description 6
- 230000033764 rhythmic process Effects 0.000 claims description 6
- 206010020772 Hypertension Diseases 0.000 claims description 5
- 230000001684 chronic effect Effects 0.000 claims description 5
- 230000004199 lung function Effects 0.000 claims description 5
- 230000035790 physiological processes and functions Effects 0.000 claims description 5
- 230000009325 pulmonary function Effects 0.000 claims description 5
- 201000009890 sinusitis Diseases 0.000 claims description 5
- 206010014561 Emphysema Diseases 0.000 claims description 4
- 206010016654 Fibrosis Diseases 0.000 claims description 4
- 208000029078 coronary artery disease Diseases 0.000 claims description 4
- 238000002592 echocardiography Methods 0.000 claims description 4
- 230000004761 fibrosis Effects 0.000 claims description 4
- 208000019622 heart disease Diseases 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 238000009613 pulmonary function test Methods 0.000 claims description 4
- 230000003068 static effect Effects 0.000 claims description 4
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 3
- 208000033116 Asbestos intoxication Diseases 0.000 claims description 3
- 206010003658 Atrial Fibrillation Diseases 0.000 claims description 3
- 206010003662 Atrial flutter Diseases 0.000 claims description 3
- 208000014085 Chronic respiratory disease Diseases 0.000 claims description 3
- 208000001640 Fibromyalgia Diseases 0.000 claims description 3
- 201000008197 Laryngitis Diseases 0.000 claims description 3
- 208000009525 Myocarditis Diseases 0.000 claims description 3
- 206010028735 Nasal congestion Diseases 0.000 claims description 3
- 206010033078 Otitis media Diseases 0.000 claims description 3
- 201000007100 Pharyngitis Diseases 0.000 claims description 3
- 208000032056 Radiation Fibrosis Syndrome Diseases 0.000 claims description 3
- 206010067953 Radiation fibrosis Diseases 0.000 claims description 3
- 208000003734 Supraventricular Tachycardia Diseases 0.000 claims description 3
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims description 3
- 206010003441 asbestosis Diseases 0.000 claims description 3
- 206010006451 bronchitis Diseases 0.000 claims description 3
- 210000001715 carotid artery Anatomy 0.000 claims description 3
- 206010014665 endocarditis Diseases 0.000 claims description 3
- 230000001631 hypertensive effect Effects 0.000 claims description 3
- 230000001969 hypertrophic effect Effects 0.000 claims description 3
- 230000002757 inflammatory effect Effects 0.000 claims description 3
- 230000007774 longterm Effects 0.000 claims description 3
- 208000037841 lung tumor Diseases 0.000 claims description 3
- 201000002859 sleep apnea Diseases 0.000 claims description 3
- 101100503323 Artemisia annua FPS1 gene Proteins 0.000 claims description 2
- 101100503326 Gibberella fujikuroi FPPS gene Proteins 0.000 claims description 2
- 230000036997 mental performance Effects 0.000 claims description 2
- 230000036314 physical performance Effects 0.000 claims description 2
- 201000000306 sarcoidosis Diseases 0.000 claims description 2
- NCGICGYLBXGBGN-UHFFFAOYSA-N 3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine;hydrochloride Chemical compound Cl.[N-]1OC(=N)C=[N+]1N1CCOCC1 NCGICGYLBXGBGN-UHFFFAOYSA-N 0.000 claims 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 13
- 229910052760 oxygen Inorganic materials 0.000 abstract description 13
- 239000001301 oxygen Substances 0.000 abstract description 13
- 230000009471 action Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 239000007789 gas Substances 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 19
- 201000010099 disease Diseases 0.000 description 17
- 210000003097 mucus Anatomy 0.000 description 15
- 230000029058 respiratory gaseous exchange Effects 0.000 description 12
- 230000001515 vagal effect Effects 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- 210000000214 mouth Anatomy 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 7
- 230000002889 sympathetic effect Effects 0.000 description 7
- 208000000059 Dyspnea Diseases 0.000 description 6
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 208000019693 Lung disease Diseases 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 230000001734 parasympathetic effect Effects 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- 238000009987 spinning Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 230000004087 circulation Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 206010037423 Pulmonary oedema Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000002996 emotional effect Effects 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 210000000779 thoracic wall Anatomy 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000002567 autonomic effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000004630 mental health Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 210000003123 bronchiole Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000009084 cardiovascular function Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 201000003651 pulmonary sarcoidosis Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000004648 relaxation of smooth muscle Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010049694 Left Ventricular Dysfunction Diseases 0.000 description 1
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 1
- 208000011623 Obstructive Lung disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 208000004301 Sinus Arrhythmia Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 210000004712 air sac Anatomy 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 108091008698 baroreceptors Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000002564 cardiac stress test Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000001308 heart ventricle Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001242 postsynaptic effect Effects 0.000 description 1
- 210000001774 pressoreceptor Anatomy 0.000 description 1
- 230000003518 presynaptic effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004088 pulmonary circulation Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000036593 pulmonary vascular resistance Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000036391 respiratory frequency Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000011947 six minute walk test Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000013125 spirometry Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000037905 systemic hypertension Diseases 0.000 description 1
- 229940126703 systemic medication Drugs 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M16/0006—Accessories therefor, e.g. sensors, vibrators, negative pressure with means for creating vibrations in patients' airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/0057—Pumps therefor
- A61M16/0066—Blowers or centrifugal pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
- A61M2016/102—Measuring a parameter of the content of the delivered gas
- A61M2016/103—Measuring a parameter of the content of the delivered gas the CO2 concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
- A61M2016/102—Measuring a parameter of the content of the delivered gas
- A61M2016/1035—Measuring a parameter of the content of the delivered gas the anaesthetic agent concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0088—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus modulated by a simulated respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/30—Blood pressure
Landscapes
- Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Percussion Or Vibration Massage (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18523009P | 2009-06-09 | 2009-06-09 | |
| US61/185,230 | 2009-06-09 | ||
| PCT/IL2009/000962 WO2011007346A1 (en) | 2009-06-09 | 2009-10-11 | Device and methods for applying therapeutic protocols to organs of the cardiopulmonary system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2764877A1 true CA2764877A1 (en) | 2011-01-20 |
Family
ID=43448997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2764877A Abandoned CA2764877A1 (en) | 2009-06-09 | 2009-10-11 | Device and methods for applying therapeutic protocols to organs of the cardiopulmonary system |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9114224B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2440274B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5809622B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN102458544B (cg-RX-API-DMAC10.html) |
| CA (1) | CA2764877A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2011007346A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10646668B2 (en) * | 2005-06-02 | 2020-05-12 | Respinova Ltd. | Pulsating inhaler and a method of treating upper respiratory disorders |
| US8539952B2 (en) * | 2011-05-13 | 2013-09-24 | Hill-Rom Services Pte. Ltd. | Mechanical insufflation/exsufflation airway clearance apparatus |
| US10105505B2 (en) * | 2012-01-13 | 2018-10-23 | Respinova Ltd. | Means and method for fluid pulses |
| JP6384965B2 (ja) | 2012-11-19 | 2018-09-05 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 呼気流を増加させるための方法及び装置 |
| RU2015138433A (ru) * | 2013-02-13 | 2017-03-20 | Лон ДАРКЕТ | Система мониторинга состояния заболевания |
| US10064583B2 (en) | 2013-08-07 | 2018-09-04 | Covidien Lp | Detection of expiratory airflow limitation in ventilated patient |
| EP3030302B1 (en) | 2013-09-04 | 2023-02-22 | Fisher&Paykel Healthcare Limited | Improvements to flow therapy |
| BR112016028435B1 (pt) * | 2014-06-02 | 2021-11-09 | Respinova Ltd | Inalador pulsante |
| US11491291B2 (en) | 2015-03-31 | 2022-11-08 | Fisher & Paykel Healthcare Limited | Methods and apparatus for oxygenation and/or CO2 removal |
| EP4186548A1 (en) | 2015-04-02 | 2023-05-31 | Hill-Rom Services PTE. LTD. | Mask leakage detection for a respiratory device |
| FI126600B (en) | 2015-08-10 | 2017-03-15 | Murata Manufacturing Co | Detection of sleep phenomena using ballistocardiography |
| WO2017089369A1 (en) | 2015-11-27 | 2017-06-01 | Koninklijke Philips N.V. | A device for controlling the enrichment of nitric oxide levels and a control method |
| AU2017257442C1 (en) | 2016-04-29 | 2022-07-21 | Fisher & Paykel Healthcare Limited | Methods and apparatus for oxygenation and/or CO2 removal |
| CN112165968B (zh) * | 2018-01-12 | 2025-05-13 | 儿童医院医疗中心 | 用于从气道消除分泌物的阻塞并去除所述分泌物的装置 |
| EP3648470B1 (en) * | 2018-11-05 | 2025-06-04 | GN Hearing A/S | Hearing system with heart condition alert and related methods |
| CN119455195A (zh) * | 2019-12-16 | 2025-02-18 | 深圳迈瑞生物医疗电子股份有限公司 | 一种医疗通气设备的通气信息显示方法及装置、医疗设备 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3502094A (en) * | 1967-03-16 | 1970-03-24 | Honeywell Inc | Fluid logic circuit |
| US5862802A (en) | 1981-04-03 | 1999-01-26 | Forrest M. Bird | Ventilator having an oscillatory inspiratory phase and method |
| GB8602646D0 (en) * | 1986-02-04 | 1986-03-12 | Hayek Z | Ventilator apparatus |
| EP0563120B1 (en) * | 1990-12-17 | 1997-10-01 | Minnesota Mining And Manufacturing Company | Inhaler |
| US5211171A (en) * | 1992-01-31 | 1993-05-18 | Robert Choromokos | Portable lung purger and ventilator system |
| US5603315A (en) | 1995-08-14 | 1997-02-18 | Reliable Engineering | Multiple mode oxygen delivery system |
| US6199550B1 (en) | 1998-08-14 | 2001-03-13 | Bioasyst, L.L.C. | Integrated physiologic sensor system |
| US20070000494A1 (en) * | 1999-06-30 | 2007-01-04 | Banner Michael J | Ventilator monitor system and method of using same |
| US6581596B1 (en) * | 1999-09-24 | 2003-06-24 | Respironics, Inc. | Apparatus and method of providing high frequency variable pressure to a patient |
| ES2251416T3 (es) | 1999-12-10 | 2006-05-01 | Vapotherm, Inc. | Aparato para terapia del tracto respiratorio. |
| US6415797B1 (en) | 2000-07-07 | 2002-07-09 | First Circle Medical, Inc. | Treatment of human herpesviruses using hyperthermia |
| EP1309304A2 (en) * | 2000-07-14 | 2003-05-14 | Hill-Rom Services, Inc. | Pulmonary therapy apparatus |
| US20050066968A1 (en) * | 2000-08-01 | 2005-03-31 | Shofner Frederick M. | Generation, delivery, measurement and control of aerosol boli for diagnostics and treatments of the respiratory/pulmonary tract of a patient |
| SE0200300D0 (sv) * | 2002-02-01 | 2002-02-01 | Aerocrine Ab | Diagnostic device and method |
| UA90651C2 (uk) * | 2002-10-09 | 2010-05-25 | Компьюмедикс Лимитед | Спосіб та пристрій для підтримування та контролювання якості сну при терапевтичному лікуванні |
| WO2005007023A2 (en) * | 2003-07-09 | 2005-01-27 | Emphasys Medical, Inc. | Treatment planning with implantable bronchial isolation devices |
| CN102512736B (zh) * | 2004-10-20 | 2015-09-02 | 瑞思迈有限公司 | 检测无效吸气努力并改进患者-呼吸机相互作用的系统 |
| WO2006129305A2 (en) * | 2005-06-02 | 2006-12-07 | Ads & B Investmentfund L.P | A vibrating device for treating nasal congestion and sinusitis symptoms and method thereof |
| IL168975A (en) | 2005-06-02 | 2014-11-30 | Respinova Ltd | Pulse inhalator for upper respiratory tract disease |
| US8105249B2 (en) * | 2006-02-16 | 2012-01-31 | Zoll Medical Corporation | Synchronizing chest compression and ventilation in cardiac resuscitation |
| US8051854B2 (en) * | 2006-09-15 | 2011-11-08 | Comedica Incorporated | Continuous high-frequency oscillation breathing treatment apparatus |
| US7779841B2 (en) * | 2006-11-13 | 2010-08-24 | Carefusion 2200, Inc. | Respiratory therapy device and method |
| AU2008326425B2 (en) * | 2007-11-19 | 2012-04-26 | Sunmed Group Holdings, Llc | Patient interface assembly for respiratory therapy |
| EP2067497B1 (en) * | 2007-12-05 | 2017-02-15 | Vectura GmbH | Methods, systems and computer-readable products for optimizing aerosol particle administration to the lungs |
| EP2320821B2 (en) * | 2008-05-09 | 2020-12-30 | Nuvaira, Inc. | Systems for treating a bronchial tree |
| EP2506909B1 (en) * | 2009-12-02 | 2018-10-31 | Respinova Ltd. | Drug delivery device |
-
2009
- 2009-10-11 CA CA2764877A patent/CA2764877A1/en not_active Abandoned
- 2009-10-11 JP JP2012514590A patent/JP5809622B2/ja not_active Expired - Fee Related
- 2009-10-11 CN CN200980160862.8A patent/CN102458544B/zh not_active Expired - Fee Related
- 2009-10-11 US US13/377,087 patent/US9114224B2/en active Active
- 2009-10-11 EP EP09847277.2A patent/EP2440274B1/en not_active Not-in-force
- 2009-10-11 WO PCT/IL2009/000962 patent/WO2011007346A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US9114224B2 (en) | 2015-08-25 |
| EP2440274A4 (en) | 2016-03-23 |
| CN102458544A (zh) | 2012-05-16 |
| EP2440274A1 (en) | 2012-04-18 |
| JP5809622B2 (ja) | 2015-11-11 |
| US20120103337A1 (en) | 2012-05-03 |
| WO2011007346A1 (en) | 2011-01-20 |
| EP2440274B1 (en) | 2021-11-24 |
| CN102458544B (zh) | 2015-03-18 |
| JP2012529334A (ja) | 2012-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9114224B2 (en) | Device and methods for applying therapeutic protocols to organs of the cardiopulmonary system | |
| CN101528289B (zh) | 用于控制呼吸速率的系统和方法 | |
| US10531827B2 (en) | Apparatus and method for beneficial modification of biorhythmic activity | |
| EP2506909B1 (en) | Drug delivery device | |
| CN102056536B (zh) | 用于保持主体状态的方法和系统 | |
| Srivastava et al. | Influence on alternate nostril breathing on cardiorespiratory and autonomic functions in healthy young adults | |
| Cernes et al. | RESPeRATE: the role of paced breathing in hypertension treatment | |
| JP2021509108A (ja) | 肺高血圧症の治療のための吸入用一酸化窒素及び酸素の使用 | |
| Sathe et al. | Immediate effect of Buteyko breathing and Bhramari pranayama on blood pressure, heart rate and oxygen saturation in hypertensive patients: a comparative study | |
| RU2221477C2 (ru) | Способ функциональной психофизиологической коррекции состояния человека и диагностики в процессе коррекции | |
| Hu et al. | The role of high-frequency jet ventilation in the treatment of Cheyne–Stokes respiration in patients with chronic heart failure | |
| US20260097174A1 (en) | Oral positive expiratory pressure device | |
| RU2197280C2 (ru) | Способ гипокситерапии - резонансная прерывистая нормобарическая гипокситерапия | |
| Roy et al. | PULMONARY REHABILITATION | |
| Chaiduang | The effect of breathing exercise on hemodynamics and heart rate variability parameters in hypertensive patients | |
| RU2655883C1 (ru) | Способ функциональной психофизиологической коррекции состояния человека | |
| Saarnivaara et al. | Electrocardiographic changes during microlaryngoscopy in practolol‐pretreated patients under balanced anaesthesia | |
| RU2013988C1 (ru) | Способ лечения бронхиальной астмы | |
| Fried | Respiration in clinical psychophysiology: how to assess critical parameters and their change with treatment | |
| Ekkernkamp et al. | 243. Advanced experience with long-term noninvasive ventilation and late-breaking | |
| Sheldon | Rehabilitation in chronic obstructive airway disease | |
| Fuchs et al. | Music-Based Interventions to Reduce Blood Pressure: Results from a Randomized Controlled Trial | |
| HK1108107A (en) | Apparatus and method for beneficial modification of biorhythmic activity | |
| Herath et al. | Efficacy of Involuntary Deep Breathing by Postural-Respiration Feedback Control System |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20131011 |